Ink Innovation and Riyadh Air Partner to Rethink Experience for Digital-first Travellers
13.5.2025 11:06:00 CEST | Business Wire | Press Release
Riyadh Air, the digitally native national carrier of Saudi Arabia, is joining forces with Ink Innovation to deliver a flexible and convenient air travel experience. Together, they aim to redefine standards of delivery management in a world influenced by e-commerce, cloud computing, and evolving traveller expectations.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250513792260/en/
Tony Douglas, CEO of Riyadh Air, said:
“Ink is a key partner to Riyadh Air and continues to foster innovation at every step of the journey. As a like-minded tech-innovator, it is an ideal collaborator as we aim to provide an outstanding digital experience for our guests at their first travel touchpoint.”
Moving beyond legacy systems
Airlines have long struggled with outdated infrastructure—systems built to move passengers from point A to B, but not to delight or adapt. This partnership aims to change that.
Riyadh Air and Ink are implementing a full Delivery Management System aligned with the IATA Modern Airline Retailing (MAR) model. The platform lets you manage and interact with orders in real time, without outdated systems that rely on PNLs or PNRs. This puts travellers in charge of their journeys.
Passengers will be able to make changes on-the-go, add services mid-trip, and connect with third-party content in one streamlined experience. Instead of static, pre-booked trips, travel becomes modular, personal, and responsive.
Proven in the field
The system has already proven its readiness. Riyadh Air achieved its Air Operator Certificate using Ink’s platform, with proving flights across continents. All flight handling, check-in, and load control functions were completed using Ink’s digital tools.
By leveraging mobile-based operations and cloud-native architecture, Riyadh Air teams can respond instantly to passenger or operational needs, whether a last-minute seat change or managing disrupted flights without the drama typical of legacy systems.
From airline to travel ecosystem
The broader ambition goes well beyond the airport terminal experience and check-in upgrade. Ink and Riyadh Air have built their system to connect travellers to hotels, airport transfers, local experiences, and multimodal transport like rail. It is designed to support upselling, cross-selling, and personalised service delivery, all aligned with the modern expectations of today’s traveller.
“We are developing a platform that aligns perfectly with the Modern Airline Retailing model,” said Shawn Richards, CEO and Co-Founder of Ink Innovation. “Our vision for travel is about empowering passengers much more than they are today. We believe that travellers will want the ability to change, enhance, or remove parts of their journey with ease. Right now, that's not possible.”
While many airlines continue to plan digital upgrades and launch Delivery systems in 2027 and beyond, Riyadh Air and Ink will fully deploy this system in 2025.
Ink provides a dynamic platform designed to evolve with passenger travel.
About Riyadh Air
Riyadh Air, owned by PIF, is a world-class airline. Launched in March 2023, the airline will be a digitally led, full-service airline that adopts the best global sustainability and safety practices across its advanced fleet of aircraft. Riyadh Air will connect guests to over 100 destinations around the world by 2030 through offering an exceptional guest experience with an authentic, warm Saudi hospitality at its heart.
Website: www.riyadhair.com
About Ink Innovation (Ink)
Ink provides a dynamic platform of cloud-hosted systems, self-service devices, and mobile/browser-based solutions for airport and airline operations. It is designed to evolve with passenger travel. Founded in 2011, based in Spain, Ink operates globally, partnering with clients such as Copenhagen Airport, JFK Terminal One, Jet2, TUIfly, Marabu, Lift, and Menzies Aviation.
Website: www.innovation.ink.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250513792260/en/
Contacts
Contact information:
Elena Popova, Ekaterina Arkadeva
media@innovation.ink
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom